Amin Polzin (@amin_polzin) 's Twitter Profile
Amin Polzin

@amin_polzin

Interventional Cardiologist, Scientist

ID: 1380992710451027970

calendar_today10-04-2021 21:15:06

41 Tweet

143 Followers

110 Following

Amin Polzin (@amin_polzin) 's Twitter Profile Photo

#dgkherztage 2023 A pleasure to share again this year some of our newest research results at the #WorldConferenceCenterBonn. Thanks for interesting talks and networking! Deutsche Gesellschaft für Kardiologie @YounDgk Saif Zako Philipp Mourikis #Cardiology

#dgkherztage 2023 
A pleasure to share again this year some of our newest research results at the #WorldConferenceCenterBonn.  Thanks for interesting talks and networking! <a href="/DGK_org/">Deutsche Gesellschaft für Kardiologie</a> @YounDgk <a href="/saif_zako/">Saif Zako</a> <a href="/ph_mourikis/">Philipp Mourikis</a> #Cardiology
Amin Polzin (@amin_polzin) 's Twitter Profile Photo

We are proud to announce that the cardiology team at Uniklinik Düsseldorf successfully performed the first interventional transfemoral tricuspid valve replacement this week! A huge thank you to the entire team!

Tobias Petzold (@petzold_tobias) 's Twitter Profile Photo

Happy to announce that our new lab in Berlin Deutsches Herzzentrum der Charité is recruiting! We are offering PhD and postdoc positions. Join our exciting journey to discover and to translate novel mechanism in thromboinflammation - within an fantastic team -apply: karriere.charite.de/en/job-vacanci…

Amin Polzin (@amin_polzin) 's Twitter Profile Photo

Dr. rer. nat. Benkhoff had the opportunity to give a presentation on "S1P reduces arterial thrombosis via endothelial thrombomodulin expression by S1PR1 signaling" at the #esc2024 and was able to discuss our research group’s findings. We returned with many impressions and ideas!

Dr. rer. nat. Benkhoff had the opportunity to give a presentation on "S1P reduces arterial thrombosis via endothelial thrombomodulin expression by S1PR1 signaling" at the #esc2024 and was able to discuss our research group’s findings. We returned with many impressions and ideas!
Amin Polzin (@amin_polzin) 's Twitter Profile Photo

Thromboinflammation is associated with clinical outcome after ST-elevation myocardial infarction ashpublications.org/bloodadvances/… #newpuplication #Cardiology #clinicalresearch

Elric Zweck (@elriczweck) 's Twitter Profile Photo

Out now in Circulation: an in-depth analysis of #renal risk factors and outcomes in the #DanGer #shock trial. Led by pioneer #JacobEMoller. Accompanied by an excellent editorial by Saraschandra Vallabhajosyula, MD MSc. Christian Hassager Ralf Westenfeld Amin Polzin doi.org/10.1161/CIRCUL…

Circulation (@circaha) 's Twitter Profile Photo

Could sphingosine-1-phosphate (S1P) be the key to tackling aortic valve disease (AVD)? Study reveals S1P/S1P receptor 2 (S1PR2) signaling accelerates valve calcification while S1PR2 inhibition prevents disease progression in mice. ahajournals.org/doi/abs/10.116…

Could sphingosine-1-phosphate (S1P) be the key to tackling aortic valve disease (AVD)? Study reveals S1P/S1P receptor 2 (S1PR2) signaling accelerates valve calcification while S1PR2 inhibition prevents disease progression in mice. ahajournals.org/doi/abs/10.116…
Amin Polzin (@amin_polzin) 's Twitter Profile Photo

I'm very happy to present another research paper from our group. doi.org/10.1161/CIRCUL… #herzklappe #valve #valvedisease #cardiology #research #clinical #clinicalresearch #sphingosine1phosphate #stenosis #signaling #circulacion #heart #heartdisease

JACC Journals (@jaccjournals) 's Twitter Profile Photo

#AHA24: How does the benefit of microaxial flow pumps in cardiogenic shock vary by age? In a new analysis of the DanGer Shock trial, Dr. Jacob Møller & team at Research Unit of Cardiology, OUH find that these devices may not benefit older patients (>77 y/o) bit.ly/3Z56S3L #JACC #cvGeri

#AHA24: How does the benefit of microaxial flow pumps in cardiogenic shock vary by age? In a new analysis of the DanGer Shock trial, Dr. Jacob Møller &amp; team at <a href="/CardResearchOuh/">Research Unit of Cardiology, OUH</a> find that these devices may not benefit older patients (&gt;77 y/o) bit.ly/3Z56S3L

#JACC #cvGeri
Amin Polzin (@amin_polzin) 's Twitter Profile Photo

Our next Publication is out!! 💪🏽🧬 #lipids are not always the bad guys but might exert lipoprotection of #cardiovascular #diseases. New review on concepts and options of #lipoprotection doi.org/10.1016/j.phar… #Cardiology #review

Our next Publication is out!! 💪🏽🧬
#lipids are not always the bad guys but might exert lipoprotection of #cardiovascular #diseases. New review on concepts and options of #lipoprotection 
doi.org/10.1016/j.phar…
#Cardiology #review
JTH (@jthjournal) 's Twitter Profile Photo

Long-term FXa inhibition induces anti-thromboinflammatory proteome signatures in platelets, improving infarct size after myocardial infarction and stroke. jthjournal.org/article/S1538-…

Long-term FXa inhibition induces anti-thromboinflammatory proteome signatures in platelets, improving infarct size after myocardial infarction and stroke.

jthjournal.org/article/S1538-…
JTH (@jthjournal) 's Twitter Profile Photo

#2 of our Top 10 Altmetric Papers of 2024 Countdown! 2️⃣ Long-term FXa inhibition attenuates thromboinflammation after acute myocardial infarction and stroke by platelet proteome alteration 🔬 Breakthrough in managing thromboinflammation. 📅 Published: 16 Nov 2024 🔗